Zobrazeno 1 - 10
of 156
pro vyhledávání: '"Francis P. Tally"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2010 Jan 01; Vol. 50 Suppl 1, pp. S1-26.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Antimicrobial Chemotherapy. 55:283-288
Infections caused by drug-resistant pathogens are on the rise. Daptomycin, a cyclic lipopeptide with activity against most Gram-positive pathogens, including vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus, is a newly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7640ace85683a6d385417434ad6519ae
https://doi.org/10.1093/jac/dkh546
https://doi.org/10.1093/jac/dkh546
Publikováno v:
Infectious Diseases in Clinical Practice. 12:322-327
Background:Complicated urinary tract infections (UTIs) due to Gram-positive pathogens are of increasing concern because of steadily emerging resistance to standard antibiotic therapy. Daptomycin is the first available agent of a new class of antibiot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8e3e95756694bf74dc4f387aed9fb916
https://doi.org/10.1097/01.idc.0000144898.12957.eb
https://doi.org/10.1097/01.idc.0000144898.12957.eb
Autor:
Francis P. Tally, Kenneth V. I. Rolston, Manjari Joshi, George A. Pankey, Robert W. Finberg, Michael West, E. Patchen Dellinger, William A. Craig, Peter K. Linden, Michael J. Rybak, John C. Rotschafer, Robert C. Moellering
Publikováno v:
Clinical Infectious Diseases. 39:1314-1320
Background. Although a considerable amount of research has gone into the study of the role of bactericidal versus bacteriostatic antimicrobial agents in the treatment of different infectious diseases, there is no accepted standard of practice. Method
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18dc5a0f00a5436c5bba43f7623523e4
https://doi.org/10.1086/425009
https://doi.org/10.1086/425009
Autor:
Michael F. DeBruin, Francis P. Tally
Publikováno v:
Journal of Antimicrobial Chemotherapy. 46:523-526
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbe146e77e3ca70637471057fbc3d77c
https://doi.org/10.1093/jac/46.4.523
https://doi.org/10.1093/jac/46.4.523
Autor:
William J. Weiss, Subas M. Sakya, Nilda V. Jacobus, Francis P. Tally, Karen Bush, Panayota Bitha, Lin Yang I, Stanley A. Lang, Strohmeyer Timothy W, Peter Petersen, Niraja Bhachech, Youjun Yang, Li Zhong, Testa Raymond T, Ving J. Lee
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 7:1671-1676
A series of twelve highly active aminomethyl-THF 1β-methylcarbapenems 3a-1 were synthesized. Of these, carbapenems 3a-f demonstrated a spectrum of antimicrobial activity comparable to those of imipenem and meropenem with the exception of only modera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e7cf0fda2095464b1f1974109e04d23
https://doi.org/10.1016/s0960-894x(97)00282-5
https://doi.org/10.1016/s0960-894x(97)00282-5
Autor:
Arthur Stanley Link, Marcus J. Zervos, Ignace DeMeyer, Hans Reinhardt Brodt, Marcelo Gareca, Christopher H. Cabell, Jack M. Bernstein, Henry F. Chambers, Donald P. Levine, Gerd Fätkenheuer, Jeffrey Parsonnet, Helen W. Boucher, Alan D. Tice, Adolf W. Karchmer, Gloria Vigliani, Vance G. Fowler, Scott G. Filler, Mark E. Rupp, Graeme N. Forrest, Paul P. Cook, Sara E. Cosgrove, Elias Abrutyn, Connie S. Price, G. Ralph Corey, Francis P. Tally, Susan J. Rehm
Publikováno v:
The New England journal of medicine. 355(7)
Alternative therapies for Staphylococcus aureus bacteremia and endocarditis are needed.We randomly assigned 124 patients with S. aureus bacteremia with or without endocarditis to receive 6 mg of daptomycin intravenously per kilogram of body weight da
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d745ef7f2e3fc1da4d06a16802a1e2fb
https://pubmed.ncbi.nlm.nih.gov/17120350
https://pubmed.ncbi.nlm.nih.gov/17120350
Autor:
Francis P. Tally, Claudio Carini, Michael L Zeckel, Frederick B. Oleson, Cindy L Berman, Margaret M Wasilewski, George L Drusano
Publikováno v:
Expert opinion on investigational drugs. 8(8)
The alarming increase in the incidence of Gram-positive infections, including those caused by resistant bacteria, has sparked renewed interest in novel antibiotics. One such agent is daptomycin, a novel lipopeptide antibiotic with proven bactericidal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5195e56c69c37e8d57696afa40d2c64
https://pubmed.ncbi.nlm.nih.gov/15992147
https://pubmed.ncbi.nlm.nih.gov/15992147